Holen Sie sich die Stockscreener-App
37.50
1.68%
0.62
Vorhandelsmarkt:
38.60
1.10
+2.93%
Schlusskurs vom Vortag:
$36.88
Offen:
$37.18
24-Stunden-Volumen:
261.15K
Relative Volume:
2.06
Marktkapitalisierung:
$549.47M
Einnahmen:
$138.20M
Nettoeinkommen (Verlust:
$5.52M
KGV:
98.68
EPS:
0.38
Netto-Cashflow:
$9.86M
1W Leistung:
+5.49%
1M Leistung:
-5.66%
6M Leistung:
-9.99%
1J Leistung:
+10.39%
1-Tages-Spanne:
$37.10
$37.83
1-Wochen-Bereich:
$35.78
$37.83
52-Wochen-Spanne:
$25.17
$42.44
Surmodics Inc Stock (SRDX) Company Profile
Firmenname
Surmodics Inc
Sektor
Branche
Telefon
(952) 500-7000
Adresse
9924 W 74TH ST, EDEN PRAIRIE, MN
Vergleichen Sie SRDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
37.50 | 549.47M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-06-13 | Hochstufung | Needham | Hold → Buy |
| 2023-02-13 | Herabstufung | Needham | Buy → Hold |
| 2020-07-23 | Hochstufung | Needham | Hold → Buy |
| 2019-12-11 | Herabstufung | Needham | Buy → Hold |
| 2019-11-01 | Herabstufung | Lake Street | Buy → Hold |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Lake Street | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-02-21 | Bestätigt | Needham | Buy |
| 2018-05-16 | Bestätigt | Needham | Buy |
| 2018-03-01 | Hochstufung | Sidoti | Neutral → Buy |
| 2018-02-28 | Bestätigt | Lake Street | Buy |
| 2018-02-28 | Eingeleitet | Needham | Buy |
| 2017-07-14 | Eingeleitet | Lake Street | Buy |
| 2016-11-21 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-10-06 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-05-03 | Bestätigt | Barrington Research | Outperform |
| 2015-08-06 | Bestätigt | Barrington Research | Outperform |
| 2015-03-27 | Eingeleitet | Dougherty & Company | Buy |
| 2014-02-25 | Eingeleitet | Laidlaw | Buy |
| 2013-08-01 | Hochstufung | Feltl & Co. | Buy → Strong Buy |
| 2012-11-12 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Surmodics Inc Aktie (SRDX) Neueste Nachrichten
Surmodics (NASDAQ:SRDX) Coverage Initiated by Analysts at StockNews.com - MarketBeat
After Plunging -10.42% in 4 Weeks, Here's Why the Trend Might Reverse for SurModics (SRDX) - Yahoo Finance
Surmodics drops after report on FTC's view on planned sale to GTCR (SRDX:NASDAQ) - Seeking Alpha
Matterport, Surmodics drop amid news of FTC closed door meeting next week - MSN
Surmodics (SRDX) Shares Cross Below 200 DMA - Nasdaq
Matterport, Surmodics drop amid news of FTC closed door meeting next week (MTTR:NASDAQ) - Seeking Alpha
Surmodics (NASDAQ:SRDX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Surmodics (FRA:SU6) 5-Day RSI : 39.40 (As of Jan. 09, 2025) - GuruFocus.com
AtriCure (NASDAQ:ATRC) versus Surmodics (NASDAQ:SRDX) Head to Head Analysis - Defense World
Jane Street Group LLC Has $522,000 Stock Position in Surmodics, Inc. (NASDAQ:SRDX) - Defense World
Principal Financial Group Inc. Invests $1.19 Million in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
SurModics (SRDX) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance
Best Momentum Stocks to Buy for January 3rd - Yahoo Finance
Objective long/short (SRDX) Report - Stock Traders Daily
Surmodics (NASDAQ:SRDX) Now Covered by Analysts at StockNews.com - Defense World
Surmodics (NASDAQ:SRDX) Now Covered by StockNews.com - MarketBeat
Geode Capital Management LLC Has $12.59 Million Position in Surmodics, Inc. (NASDAQ:SRDX) - Defense World
State Street Corp Buys 60,240 Shares of Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics, Inc. (NASDAQ:SRDX) Shares Acquired by State Street Corp - Defense World
StockNews.com Begins Coverage on Surmodics (NASDAQ:SRDX) - MarketBeat
Barclays PLC Buys 12,271 Shares of Surmodics, Inc. (NASDAQ:SRDX) - Defense World
(SRDX) Technical Data - Stock Traders Daily
BNP Paribas Financial Markets Sells 4,994 Shares of Surmodics, Inc. (NASDAQ:SRDX) - Defense World
StockNews.com Initiates Coverage on Surmodics (NASDAQ:SRDX) - Defense World
Charles Schwab Investment Management Inc. Increases Position in Surmodics, Inc. (NASDAQ:SRDX) - Defense World
Oddo BHF Asset Management Sas Takes Position in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
How to Take Advantage of moves in (SRDX) - Stock Traders Daily
Disciplined Growth Investors Inc. MN Sells 303,690 Shares of Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Why Is SurModics (SRDX) Up 4% Since Last Earnings Report? - Yahoo Finance
Murchinson Ltd. Purchases Shares of 55,000 Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Trend Tracker for (SRDX) - Stock Traders Daily
Surmodics (NASDAQ:SRDX) Coverage Initiated at StockNews.com - MarketBeat
Q2 Earnings Estimate for Surmodics Issued By Zacks Research - MarketBeat
Zacks Research Increases Earnings Estimates for Surmodics - Defense World
Insider Sell: Timothy Arens Sells 7,009 Shares of Surmodics Inc (SRDX) - GuruFocus.com
Zacks Research Brokers Lift Earnings Estimates for Surmodics - MarketBeat
SRDX (Surmodics) Cyclically Adjusted PS Ratio : 4.90 (As of Nov. 26, 2024) - GuruFocus.com
Principal Financial Group Inc. Purchases Shares of 30,696 Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
SurModics Inc. Faces Legal Hurdles: Shareholder Lawsuits Threaten Merger and Financial Stability - Yahoo Finance
The Gory Details on SurModics's Double Miss - AOL
(SRDX) Long Term Investment Analysis - Stock Traders Daily
Surmodics Inc. (SRDX) reports earnings - Quartzy
Nashville InnoSurmodics adds to med-device portfolio with $39.9M acquisition of Vetex Medical - The Business Journals
Phocas Financial Corp. Invests $3.43 Million in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Finanzdaten der Surmodics Inc-Aktie (SRDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):